Levetiracetam 51224-0013-25
- Manufacturer
- Tagi Pharma, Inc.
- Dosage Form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 30, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA209781
Need to source Levetiracetam? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Levetiracetam | 100 mg/mL |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
51224-0013-25Selected25 VIAL, SINGLE-USE in 1 CARTON (51224-013-25) / 5 mL in 1 VIAL, SINGLE-USE
Other packages for this product(1)
10 VIAL, SINGLE-USE in 1 CARTON (51224-013-10) / 5 mL in 1 VIAL, SINGLE-USE